Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review

IntroductionOptimal anticoagulation therapy is essential for the prevention of thrombotic and hemorrhagic complications in pediatric patients supported with extracorporeal membrane oxygenation (ECMO). Recent data have demonstrated bivalirudin has the potential to surpass and replace heparin as the a...

Full description

Bibliographic Details
Main Authors:	Carlos A. Valdes, Omar M. Sharaf, Mark S. Bleiweis, Jeffrey P. Jacobs, Mohammed Mumtaz, Ramy M. Sharaf, Eric I. Jeng, Giles J. Peek
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Medicine
Subjects:	anticoagulation bivalirudin extracorporeal membrane oxygenation (ECMO) pediatric direct thrombin inhibitor
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1137134/full

Similar Items

Bivalirudin-hydrogel coatings of polyvinyl chloride on extracorporeal membrane oxygenation for anticoagulation
by: Wenqing Gao, et al.
Published: (2023-12-01)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
by: Han Zhong, et al.
Published: (2020-09-01)

Is it time to switch to bivalirudin for ECMO anticoagulation?
by: Amir Navaei, et al.
Published: (2023-08-01)

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions
by: Jie Gu, et al.
Published: (2023-02-01)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
by: Min Ma, et al.
Published: (2022-04-01)

Bivalirudin for cardiac catheterization in a pediatric patient with religious objection to the use of porcine-derived heparin
by: A. Caskey, et al.
Published: (2021-08-01)

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
by: Diaz Dayne, et al.
Published: (2023-09-01)

Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses
by: Mikael Lund, et al.
Published: (2021-09-01)

Anticoagulation Management during Extracorporeal Membrane Oxygenation—A Mini-Review
by: Filip Burša, et al.
Published: (2022-12-01)

Exploring potential anticoagulant drug formulations using thrombin generation test
by: Elena Zavyalova, et al.
Published: (2016-03-01)

The Changing Landscape of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation: Use of the Direct Thrombin Inhibitors
by: Cindy Neunert, et al.
Published: (2022-07-01)

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?
by: María Asunción Esteve-Pastor, et al.
Published: (2016-02-01)

Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children
by: Madhuradhar Chegondi, et al.
Published: (2022-07-01)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
by: Emre Boysan, et al.
Published: (2023-09-01)

Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01)

Comparison of anti-thrombotic strategies using Bivalirudin, Heparin plus Glycoprotein IIb/IIIa inhibitors and Unfractionated Heparin Monotherapy for patients undergoing percutaneous coronary intervention – A single centre observational study
by: Upendra Kaul, et al.
Published: (2015-07-01)

Bivalirudin resistance during heart transplantation surgery.
by: Tomasz Urbanowicz, et al.
Published: (2021-03-01)

Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review
by: Sasa Rajsic, et al.
Published: (2022-08-01)

Use of a direct thrombin inhibitor for intraoperative anticoagulation during endovascular abdominal aortic aneurysm repair in a patient with heparin-induced thrombocytopenia
by: A. E. Komlev, et al.
Published: (2021-06-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis
by: René M’Pembele, et al.
Published: (2022-07-01)

Editorial: Hemostasis in ECMO and VAD, volume II
by: Jun Teruya, et al.
Published: (2023-07-01)

A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention
by: Ke‐Xin Sun, et al.
Published: (2021-05-01)

Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial
by: Olivier van Minnen, et al.
Published: (2022-05-01)

Bivalirudin vs. Enoxaparin in Intubated COVID-19 Patients: A Pilot Multicenter Randomized Controlled Trial
by: Eugenio Garofalo, et al.
Published: (2022-10-01)

Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report
by: Xuan T. Phan, et al.
Published: (2020-12-01)

Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin-induced thrombocytopenia type II
by: Barbara Bellmann, MD, et al.
Published: (2016-04-01)

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Jiawen Li, et al.
Published: (2023-07-01)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
by: Sasa Rajsic, et al.
Published: (2022-04-01)

Treatment of malignant airway stenosis with extracorporeal membrane oxygenation under low-dose anticoagulation: A case report
by: Jingsha Zhao, et al.
Published: (2023-12-01)

Regional anticoagulation with heparin of an extracorporeal CO2 removal circuit: a case report
by: Jacopo Tramarin, et al.
Published: (2019-05-01)

Extracorporeal Membrane Oxygenation (ECMO)—A Lifesaving Technology. Review and Single-center
by: Maged Makhoul, et al.
Published: (2019-04-01)

Sodium alginate-hydrogel coatings on extracorporeal membrane oxygenation for anticoagulation
by: Wenqing Gao, et al.
Published: (2022-11-01)

Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis
by: Tia C.L. Kohs, et al.
Published: (2022-05-01)

Perioperative care in an adolescent patient with heparin-induced thrombocytopenia for placement of a cardiac assist device and heart transplantation: case report and literature review
by: Kamata M, et al.
Published: (2017-02-01)

Building an Extracorporeal Cardiopulmonary Resuscitation Program at a High-volume Extracorporeal Membrane Oxygenation Center
by: Michalakes Peter C, et al.
Published: (2023-12-01)

Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment
by: Sung Joon Han, et al.
Published: (2018-04-01)

Context-Responsive Anticoagulation Reduces Complications in Pediatric Extracorporeal Membrane Oxygenation
by: John C. Lin, et al.
Published: (2021-06-01)

How I manage drainage insufficiency on extracorporeal membrane oxygenation
by: Bishoy Zakhary, et al.
Published: (2020-04-01)

The ABCDE approach to difficult weaning from venoarterial extracorporeal membrane oxygenation
by: Christiaan L. Meuwese, et al.
Published: (2022-07-01)